Guardant Health (GH) Asset Writedowns and Impairment (2022 - 2025)
Guardant Health's (GH) quarterly Asset Writedowns and Impairment came in at $13.6 million in Q4 2025, up 171.64% quarter-over-quarter from $5.0 million in Q1 2025.
Powered by 
Analysis
Guardant Health (GH) Asset Writedowns and Impairment (2022 - 2025) Analysis & Trends
Guardant Health has disclosed Asset Writedowns and Impairment across 3 years of filings, most recently posting $13.6 million for Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to $13.6 million; the TTM figure through Jun 2026 stood at $13.6 million (up 171.64% YoY), while the FY2025 annual figure was $18.6 million, changed N/A from the prior year.
- Asset Writedowns and Impairment came in at $13.6 million for Q4 2025 at Guardant Health, up from $5.0 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $23.6 million in Q2 2023 to a low of $5.0 million in Q1 2025.
- Average Asset Writedowns and Impairment over 3 years is $10.6 million, with a median of $5.5 million recorded in 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 13.58 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Jun 30, 2023 | 23.57 Mn |
| Mar 31, 2023 | 5.49 Mn |
| Sep 30, 2022 | 5.26 Mn |